December 21, 2022
Amgen is the latest pharmaceutical giant to go to court over efforts by the U.S. Department of Health and Human Services to enforce a nationwide program that mandates discounted drug prices for people with low incomes and which Amgen says big pharmacy chains have "worked to dramatically expand" to the detriment of drugmakers.